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ABSTRACT

Ready, Andrew L. M.S.B.M.E., Purdue University, August 2014. The Effects of Chronic
Neural Implantation on Localized Vasculature. Major Professor: Kevin Otto.
Prosthetic solutions currently available range from simple devices intended for aesthetics
purposes to complex systems attempting to restore lost function and sensation; of these
methods, none show more promise in restoration of normal function and life satisfaction
than neural prosthetics. These devices directly interface with the nervous system in order
to restore realistic function and feeling to the patient, potentially returning them to how
their life once was. While in some cases patients requiring prosthetics can utilize
peripheral nerves, those who suffer from injuries or disease which cause damage to the
central nervous system can necessitate the usage of devices implanted directly into the
brain or spinal cord. Research has shown that these implants lose efficacy over time due
to the immunological reaction of the brain to injury, mirroring the foreign body response
occurring in the rest of the body; these devices become encapsulated by scar tissue and
local cells die or migrate over time. Outside of the response of cells like microglia and
astrocytes to the injury, there is another factor influencing how the brain responds to
injury: the vascular response. Previous experiments have shown the presence of visible
vasospasms during and after implantation, as well as potential vasoconstriction in
chronically implanted animals. As the vascular response can influence the survival of
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nearby cells as well as portions of the immunological response, as evidenced by stroke,
Reversible cerebral vasoconstriction syndrome (RVCS), and other disorders which occur
due to vascular abnormalities, understanding how local vasculature responds to chronic
implantation is an important step in developing methods to maintain function for
chronically implanted devices.
In order to quantify this response, we implanted shank electrodes into 12 animals and
then sacrificed them at separate time points that already have a well characterized
immunological response. The brains extracted from these animals were then sliced in
order to capture the implant intact and stained to allow for confocal imaging. These
images were then cleaned and post-processed to extract information on the blood vessels
present, allowing for the quantification of vascular segment diameter and length. Our
resulting data shows that local vasodilation occurs almost immediately following the
initial implantation, and is still occurring at 7 days afterward. Furthermore, our data
suggests that there is a degree of systemic vasodilation, as over the course of 7 days we
find an increase in the vascular diameter present in the opposite hemisphere where no
injury has occurred.

1

CHAPTER 1. INTRODUCTION

1.1

Background

Prosthetics is a continuously advancing field, with advancements striving toward the
restoration or replacement of lost function, feeling, and life satisfaction. In recent history,
the field of prosthetics has advanced from simple wood and plastic replacements to
computer controlled artificial knees and myoelectrically driven limb replacements (Ott,
Serlin, & Mihm, 2002). The optimal prosthetic device should offer restoration to both lost
function and sensation, allowing the patient to live as close to normal as they can. These
devices, however, are not yet at a developmental level where they are on par with their
undamaged counterparts. In time, those who suffer from injuries or disorders
necessitating prosthetics may not suffer from any changes to their lives, or may even
have improved capabilities in some way; however, there is still a long way to go and a lot
of research and development to be done before this is a reality.

1.1.1

Prosthetics Market and Breakdown

There are many different situations where a prosthetic may be desired or needed by a
patient including aesthetic replacements, replacements for damage brought on by disease
(Pibarot & Dumesnil, 2009), and those necessary to compensate for injury are all
potential reasons that a patient may receive a prosthetic (McGimpsey & Bradford, 2008).
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Because of this, the field of prosthetics is quite large, containing craniofacial prostheses,
neck prostheses, as well as upper and lower extremity prostheses. As an example of the
prosthetic population, there are over 1.5 million amputees in the United States alone who
utilize upper and lower limb prosthetic solutions, with this number growing by an
estimated 185,000 each year (McGimpsey & Bradford, 2008). This group includes a
large number of veterans and soldiers who have received injury during combat, but the
majority of the cases that necessitate devices like this are actually due to diabetes and
various vascular diseases (American Diabetes Association, 2005; McGimpsey &
Bradford, 2008). Other examples of the prevalence of prosthetics include the fact that
there are over 100,000 cochlear implants across the world, and the worldwide dental
prosthetics market is estimated at over 5 billion in 2013 alone (Haynes & Labadie, 2000;
McGimpsey & Bradford, 2008). Within each of these different market components, there
are many different competitors using various strategies in order to solve the same type of
issues: restoration of function or sensation.

1.1.2

Prosthetic Solutions

For those injuries or diseases which have a severe impact on life satisfaction or everyday
living, researchers have developed a number of different solutions. In the case of limb
replacement, whether due to injury or disease, some of the potential solutions to the
question of function replacement and sensory restoration that have shown the greatest
results include techniques such as Targeted Muscle Reinnervation (TMR) (T. a Kuiken,
Dumanian, Lipschutz, Miller, & Stubblefield, 2004), myoelectrically driven prosthetics
(Shannon, 1979), and joints with built-in microprocessors (Hafner, Willingham, Buell,

3
Allyn, & Smith, 2007). None of these solutions directly interface with the patient’s neural
system, but rather rely on indirect methods to receive signals for movement or to produce
a sense of sensation. The most successful of these indirect solutions is the TMR
procedure. In TMR, neurons that would normally cause movement in the missing area are
reconnected to a muscle in the chest. The prosthetic then uses the myoelectric signals
from this muscle to determine movement, and potentially uses a small motor to give a
sense of haptic feedback (T. Kuiken, Miller, & Lipschutz, 2007).
While true neural prosthetics in the field of limb replacement are still under development
and are commercially rare, devices which utilize the principles of neuroprosthetics are
becoming more and more common. A prime example of a device which can be classified
as a neuroprosthetic is a cochlear implant (Haynes & Labadie, 2000). These devices,
intended for those who have some form of hearing impairment due to middle or inner ear
damage, directly stimulate the auditory nerve located in the cochlea. While far from
perfect, these devices offer hearing and speech comprehension to those who previously
struggled with or were unable to hear. Another example of a technique utilizing a neurostimulating device is Deep Brain Stimulation (DBS) (Benabid, 2003), a procedure used in
a number of cases which involves the installation of a brain pacemaker (Perlmutter &
Mink, 2006a). This technique is commonly used for the treatment of Parkinson’s disease,
but is also approved for treating disorders like dystonia and obsessive compulsive
disorder. While the exact method through which the device influences these disorders is
not understood currently, regular electrical stimulation to regions of the brain such as the
subthalamic nucleus and the globus pallidus interna positively influence the symptoms of
the diseases and disorders this technique is approved to treat (Perlmutter & Mink, 2006b).
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Unlike cochlear implants and the devices used in DBS which only interface with the
central nervous system, limb prosthetics have two main locations where they directly can
potentially interface with the nervous system: the central nervous system, including the
brain and spinal cord, and the peripheral nervous system which includes those nerves in
the rest of the body. Individuals who suffer from limb loss alone could potentially utilize
either variety of neuroprosthetic, while patients who suffer from neurodegenerative
disease or brain/spinal damage can likely only use a device of the Central Interface
family. In these cases, the lost signal propagation from the brain makes it impossible to
record neural signals in the peripheral nervous system.

1.1.3

Neural Stimulation and Recording

Neuroprosthetics rely on communicating directly with the patient’s nervous system in
order to send and receive information using neural communication. By recording
neuronal signals intending to trigger movement and stimulating sensory nerves in
response to tactile stimulation of the prosthetic, these devices aim to restore a semblance
of normal function and sensitivity to the patient (McFarland & Wolpaw, 2011). The
stimulating aspect allows the electrode to causes changes in the local field potential,
which results in the influx of sodium into nearby neurons and the triggering of action
potentials, which in turn can lead to sensation (Chang, 1951). Recording is accomplished
through monitoring the field potential, which changes during neuronal firing and action
potential propagation. The information recorded is processed in order to separate the
spikes caused by neuronal firing from background data – the pattern behind the firing can
then be processed in order to determine meanings, such as movement or muscle
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activation. Aside from maintaining the implant, the decoding of neuronal firing into
movements is one of the major hurdles faced by neuroprosthetic devices.
There are two main ways to accomplish both the stimulation and recording necessary for
a prosthetic of this variety to function: penetrating neural implants and non-penetrating
devices. While non-penetrating devices, such as those based on Electrocorticography
(ECoG) or Electroencephalography (EEG) methods of brain stimulation and recording
partially bypass the foreign body response and cause a smaller tissue reaction within the
brain, they are currently not at a developmental stage where they can reliably stimulate or
record with the same resolution as a penetrating electrode (Krames, Peckham, & Rezai,
2009). Because of this, penetrating implants are a popular choice for research and
development in the field of neuroprosthetics; however, they often cause localized damage
to cells and disrupt vasculature in the area near the implant. This disruption leads to the
body’s foreign body response, a reaction which introduces a number of complicating
factors to the function of a neuroprosthetic (Lotfi, 2007; Polikov, Tresco, & Reichert,
2005).

1.2

Foreign Body Response

Following an injury, the body responds in order to return to homeostasis. This is
accomplished via a complex response to injury known as the foreign body response
(Kumar, Abbas, & Aster, 2003). For implants in both the brain and the periphery, this
immune response reaction is split into two stages: the acute response responding to
damage accrued during surgery and implantation, and the chronic response caused when
the body is unable to clear the implant through phagocytosis (J. Anderson, 1988).

6
In the periphery, the immune response is characterized by the local release of signaling
factors in response to injury, including cytokines and chemokines as well as histamine
and other cellular signals. The release of these factors leads to clot formation, local
vasodilation and a number of other responses including cellular recruitment and
activation. The vasodilation, as well as the chemical signals present from cells responding
to injury (including Tumor Necrosis Factor alpha and Interleukin Family 1), allows for
the migration of leukocytes and other immune cells to migrate from the vasculature into
nearby tissue, in a process known as extravasation (Ahmed, 2011a). These cells, as well
as local macrophages, change phenotype during activation to facilitate the elimination of
infectious elements, expel or encapsulate debris, and begin to repair damage to the region
(J. Anderson, 1988). In the case of debris which cannot be cleared or are resistant to
degradation, macrophages will fuse together and form foreign body giant cells,
encapsulating the debris that caused the local tissue damage. This is considered a
hallmark of chronic inflammation in response to foreign materials (J. M. Anderson,
Rodriguez, & Chang, 2008).
The peripheral immune response is mirrored in the central nervous system (CNS),
although the specifics are different. The CNS is an immune-privileged site, due to the
blood brain barrier generated by astrocytes (Becher, Prat, & Antel, 2000). Astrocytes
wrap around vasculature, creating tight end junctions which prevent extravasation of
most cell types into the brain. Due to this, the brain has its own set of immune and
support cells known as glial cells. For the tissue response, the relevant cells are microglia
and astrocytes. The microglial cells have phagocytic properties like macrophages, while
the astrocytes perform structural maintenance and help to keep the blood brain barrier
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intact (Becher et al., 2000). After injury, and the resultant blood brain barrier disruption,
immune cells from the periphery undergo extravasation into the brain; this, as well as the
chemical signals released from local cellular damage, trigger the activation and migration
of nearby microglia to the site. In acute cases, the microglia will phagocytose foreign
material and cells, and the astrocytes will recreate the blood brain barrier with a minimal
amount of scar tissue (Potter, Buck, Self, & Capadona, 2012). However, in the case of a
sustained foreign body such as an implant, when microglia fail to phagocytose the
implant they enter a state known as frustrated phagocytosis and form multi-nucleated cell
bodies reminiscent of the foreign body giant cells produced by macrophages in the
periphery (Lotfi, 2007; Polikov et al., 2005). The microglia in turn recruit additional
astrocytes, causing them to activate and migrate to the injury site to form a glial sheath in
a process known as astrogliosis (Landis, 1994; Turner et al., 1999). The sheath is
composed of scar tissue and layers of living and dead cells surrounding the implant which
eventually allows the brain to restore the blood brain barrier’s integrity and return it to a
state of immune-privilege (Turner et al., 1999).

1.3

Vascular Response to Injury

As discussed earlier, after an injury occurs vasculature has a characteristic response in the
body and plays a major role in both acute and chronic inflammation. With an acute injury,
arterioles undergo vasoconstriction followed quickly by capillary vasodilation (Newby,
2000). This leads to an increase in the amount of blood present in the region of injury as
well as the leakage of plasma (edema) which is responsible for the symptoms indicative
of inflammation including redness, swelling, heat, and pain (Ahmed, 2011a). This
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reaction and the increase in blood cause a large influx of platelets, immune cells, and
nutrients which are important for the reactive response (Ahmed, 2011b). Depending on
the severity of the damage or if an irritant material cannot be easily cleared, the tissue can
undergo a range of responses, such as a return to normal state, fibrosis, abscess formation,
or chronic inflammation. Chronic inflammation, the most common response to the
continued presence of an implant, results in the continued dilation of the local vasculature
and the region remains swollen (Ahmed, 2011a). In this situation, cells previously helpful
to the process of tissue repair become toxic rather than helpful. This potentially leads to
tissue degradation and cell destruction (Morganti-Kossmann, Rancan, Stahel, &
Kossmann, 2002).

1.3.1

Cerebral Vasculature

In order to discuss the effects of an implant in the brain and how the tissue will respond,
it is important to discuss the brain’s relationship with vasculature. The brain receives
roughly 15-20% of the total cardiac output (750 mL/min). It distributes this blood at a
rate of about 50 mL per 100 grams of tissue, which highlights the large amount of blood
and oxygen needed for brain function(Cipolla, 2009). The brain is also extremely
sensitive to the amount of blood perfusion it receives. An excess can lead to conditions
such as edema while too little can lead to ischemia and potential cell death. In order to
buffer and control the amount of blood in the brain and maintain healthy amounts of
perfusion, the brain’s vasculature has the ability to auto-regulate: by dilating and
constricting local vasculature as necessary, the brain is able to compensate for most
situations, including metabolic rate changes, blood oxygenation changes and changes in
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posture (Attwell et al., 2010). This regulation in the brain is thought to be controlled by a
number of feedback systems, including a metabolic control, a myogenic control, and a
neurogenic control system (Paulson, Strandgaard, & Edvinsson, 1990). These three
controls are hypothesized to modify the vascular diameter based on influences like local
oxygen demand caused by cellular activation, blood pressure changes across the blood
brain barrier, and direct neural stimulation (Paulson et al., 1990).

1.3.2

Cerebral Vasculature Disruption

After a traumatic brain injury (TBI), vasculature in the brain becomes less controlled.
The auto regulatory abilities of the brain tend to be disrupted or completely abolished
during the course of the injury (Janjua & Mayer, 2003).Without auto regulatory
capabilities intact, the brain's vasculature is incapable of compensating for changes in
such things as blood pressure or oxygen content, as seen in Figure 1. This figure shows
the relationship between the mean arterial pressure (MAP) and the cerebral blood flow
(CBF); in the normal curve, the CBF is buffered to 50 mL/min even as the arterial
pressure changes, while in the case of the absent autoregulatory function (potentially
caused by a TBI) the buffer is not present. This leads to a greater risk of ischemia and cell
death (Paulson et al., 1990). In addition, as with the inflammatory response in the rest of
the body, local damage will cause cells to release pro-inflammatory factors which will
cause the dilation of nearby vessels. In the brain, this vasodilation as well as the local
blood brain barrier disruption caused by the damage allows for the extravasation of
leukocytes and other immune cells into the previously immune-privileged location. The
presence of these cells in the brain can further exacerbate the inflammatory response,
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leading to a more severe reaction and increasing the risk of chronic neuroinflammation
and/or cell death (Zindler & Zipp, 2010).

Figure 1: Cerebral auto-regulation curve in Normal and Traumatic Brain Injury
Adapted from Miller’s Anesthesia 7th edition

1.4

Consequences of Chronic Cerebral Vascular Disruption

As discussed earlier, chronic inflammation due to the presence of foreign materials in the
brain which cannot be cleared can lead to tissue damage and cell death caused by
apoptosis and the release of toxins from previously helpful cells (Qin et al., 2007a). In
addition, this can also lead to a state known as vasospasm, which is commonly caused
when the chemical signaling agents released by platelets in response to vascular injury
become contractive in nature rather than relaxing (Janjua & Mayer, 2003). In these cases,
the spasming vasculature can lead to a dangerously low blood perfusion in regions of the
brain, causing further cell death. Figure 2 showcases the degree of vasoconstriction which
can occur This is especially prevalent after subarachnoid hemorrhages in the brain, but
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can also appear due to a number of other factors as in the poorly understood Reversible
Cerebral Vasculature Syndrome (RVCS) (Call et al., 1988; Sattar, Manousakis, & Jensen,
2010). Even in RVCS, which can have relatively mild symptoms in comparison to
vasospasm that can occur following subarachnoid hemorrhage, sufferers report
thunderclap headaches and a number of other neurological symptoms, the worst of which
is actual stroke. In the case of vasospasm in response to subarachnoid hemorrhage, there
is up to a 40-50% morbidity rate.

Figure 2: Vasoconstriction
Image adapted from brain-aneurysm.com
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CHAPTER 2. THE EFFECTS OF CHRONIC NEURAL IMPLANTATION ON
LOCALIZED VASCULATURE

2.1

Abstract

Neural implants offer a great deal of promise to individuals who suffer from injuries or
diseases which prevent the use of common prosthetic solutions. However, these devices
trigger a reactive foreign body response due to tissue damage caused during implantation,
leading to the generation of scar tissue as well as nearby cellular death; this causes an
eventual drop in the efficacy of the implanted device, as the scar tissue changes the local
impedance and nearby neurons die off or move away. Currently, research involving
increasing the longevity and/or function of neural implants mainly involves treating or
modifying this response, by attempting to decrease the activation of local glial cells or
applying anti-inflammatory drugs such as dexamethasone (DEX) in the hopes that this
will lessen the overall reactive tissue response or delay its activation. However, the glial
response to the injury is not the only factor that can influence the implant’s efficacy or
the reactive tissue response, and the usage of a general anti-inflammatory drug such as
dexamethasone without a complete understanding of the cerebral vasculature and its
response to an implant over time may not be a sufficient solution.
Prior research within the Neuroprostheses Research Lab at Purdue has shown the
presence of vasospasms (rapidly spasming vasculature) occasionally occurring during
cerebral surgery, as well as potential vasoconstriction in areas near an implanted
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electrode (unpublished data). Due to the high amount of blood flow required for normal
neuronal function and survival (Cipolla, 2009), these conditions could lead to local cell
death beyond what is already caused by apoptosis or damage due to the reactive tissue
response. In this paper we attempt to quantify cerebral vasculature in mice at specific
time points post implantation in order to characterize the vascular response to electrode
implantation and attempt to determine if chronic vasoconstriction, or vasospasm, occurs
in areas near the implant on a regular basis. We propose that this vascular quantification
will allow us to more completely characterize the foreign body response, and allow for
the development of measures that further improve neural prosthetic function.

2.2

Introduction

With amputations caused by disease and injury on the rise (McGimpsey & Bradford,
2008), the research and development of prosthetics which can replace lost limbs or
function continues to increase in relevance. Of the current technologies available,
prosthetics which interface directly with the nervous system offer the greatest chance at a
true restoration of what was lost. However, these devices still suffer from a number of
challenges that need to be solved before they can be successfully utilized in the market,
including signal acquisition and processing as well as electrode degradation and the
reaction of local tissue to a chronic implant (Reichert, 2008). A number of these
challenges stem from the foreign body response to implanted materials, as the body’s
reaction is to remove or segregate these materials from nearby tissue, even at the cost of
local tissue destruction (Ahmed, 2011b; Qin et al., 2007b).
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In the case of central interface devices implanted directly into the brain, the first steps of
the foreign body response involve the release of pro-inflammatory signals from damaged
cells. This in turn is followed by the dilation of nearby vasculature and the migration of
immune cells into the brain through the now-compromised blood brain barrier, as well as
the migration of local microglial cells towards the site of injury. Over time, astrocytes
will migrate towards the site of injury following signaling from microglia, and begin to
form a sheath surrounding the implant in an attempt to restore the blood brain barrier’s
integrity (Turner et al., 1999). This process can take a number of weeks to accomplish,
but can begin influencing the ability of the implant to stimulate and record from local
neurons within 7 days (Reichert, 2008). In addition to the changes in impedance caused
by the process of astrogliosis, there is a region surrounding the implant where studies
have shown a decrease in the neuronal density (Biran, Martin, & Tresco, 2005; Edell, Toi,
McNeil, & Clark, 1992), leading to further deficits in the implant’s ability to function.
There have been many attempts to deal with the symptoms of chronic implantation, with
studies targeting different aspects of the response being met with various degrees of
success (He & Bellamkonda, 2005; Marin & Fernández, 2010). Some of these include
modifications to the implant itself, such as changes to the implant’s structure to minimize
damage caused during insertion (Kozai et al., 2012; Seymour & Kipke, 2007) and the
addition of various coatings in order to prevent the adhesion of glial cells or to decrease
the impedance (Marin & Fernández, 2010). Other attempts to increase the longevity of
chronic neural implants include application of DC current in order to remove glial
scarring already present and covering the electrode sites, as well as treatment using anti-
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inflammatory drugs in order to try and decrease cellular activation in response to injury
(Nemati et al., 2013).
With the inflammatory response playing such an important role in the tissue response to
an implant, understanding trends in how local blood vessels change after implantation is
an important towards a more accurate quantification of the foreign body response. While
too much vasodilation in response to the injury can lead to damaging consequences for
local tissue, too much vasoconstriction in the area can lead to similarly damaging states.
With previous research showing vasospasms occurring during electrode implantation as
well as apparent vasoconstriction near an implant at a chronic time point, we decided to
investigate the potential for vasoconstriction in the vasculature surrounding the implant.
For this experiment, we hypothesized that the vasculature local to the implant would
undergo vasoconstriction by up to 7 days post implantation, and that vasculature in the
hemisphere of the brain opposite the site of injury would have no changes in vascular
diameter.

2.3

Materials and Methods

2.3.1

Animals

All animals used in this study were handled in accordance to the ethical treatment of
animals guidelines from the Purdue Animal Care and Use Committee (PACUC). The
animals utilized in this study were transgenic mice originating from the University of
Wisconsin, but a similar strain is now available from JAX. The strain these animals
belong to is titled CX3CR1-GFP due to the insertion of a GFP sequence following the
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promoter for CX3CR1, a transmembrane protein shown to be present in monocyte
derived immune cells present in the periphery and central nervous system which also
plays a part in microglial activation and migration (Jung et al., 2000). By using these
mice for our experiment it allows us to monitor the location and morphology of
microglial cells in the brain, as well as potentially allowing us to image immune cells
from the periphery that are migrating to the site of injury. Through monitoring microglial
activation in response to penetrating injury alongside the vascular response, we hope to
be able to determine relationships between the two aspects of the reactive tissue response
while also setting baseline values for future research. 14 animals at 2 months of age were
used in the study, with 12 of them surviving surgery. This gave us 4 animals to be
sacrificed at 0 (30 minutes – 1 hour following initial implant), 3, and 7 days post
implantations.

2.3.2

Surgery

Surgeries were performed using the Purdue Neuroprostheses Research Lab's standard
anesthesia protocol (Andrew J Woolley, Desai, Steckbeck, Patel, & Otto, 2011), which
utilizes isoflurane anesthesia during surgery with a follow-up meloxicam analgesic postsurgery. Michigan shank dummy electrodes were affixed to metal rods and were cleaned
prior to application through plasma sterilization via Sterrad. Other surgical articles
required for surgery were sterilized via autoclave.
To begin, the heads were shaved and cleaned with betadine and ethanol following the
application of a stereotaxic setup. Injection of lidocaine below the scalp was performed
prior to the incision for localized anesthesia – after the initial incision, blunt dissection of
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the periosteum was used to expose the skull. Craniotomies were drilled posterior to the
bregma, and then electrodes were affixed to an automated insertion device. The
implantations were performed utilizing a computer controlled insertion rig to control for
the depth and force applied to the implant during insertion, as varying the insertion rate
can change the amount of cerebral damage caused during implantation (Bjornsson et al.,
2006). Electrodes were inserted 2mm into the cortex at a rate of 1mm/s, and then clipped
from the insertion rig using scissors to allow for closing of the craniotomy. Following
implantation, Gelfoam was used to pack the craniotomy, with a series of follow-up
applications of UV dental acrylic in order to seal the region and minimize confounding
factors including further foreign material contamination or brain exposure. Animals were
then taken off isoflurane, and placed on oxygen until they recovered normal locomotion
ability. Animals received injections of meloxicam diluted in saline each day for 3 days
following surgery to minimize stress and pain following surgery.

2.3.3

Perfusion

Animals were sacrificed at 0, 3, and 7 day time points after surgery in order to examine
the course of vascular response to injury within a time frame already well characterized
in microglial and astrocyte activation. Previous research has shown that the blood brain
barrier is disrupted immediately after cerebral damage (A.J. Woolley, Desai, Gaire,
Ready, & Otto, 2013), but the overall cellular response is slightly delayed from the onset
of the injury. Sacrifice was performed via isoflurane anesthesia followed by PBS and 4%
PFA transcardial perfusion and head removal. In order to prevent vessel dilation and
damage from occurring during perfusion, special care was taken to keep the perfusion
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pressure at or below physiological levels 120 mm Hg (Mattson, 2001). Heads were
soaked in 4% PFA to facilitate tissue fixation overnight, followed by three 4 hour washes
of PBS to remove excess paraformaldehyde. Brains were extracted via rangiers and then
sliced using a vibratome along the coronal plane, following the previously published
Device Capture Histology (DCHIST) protocol (Andrew J Woolley, Desai, Gaire, Ready,
& Otto, 2013).

Figure 3: Brain Diagram
Example image of brain slice containing implant. Brain image from 3D VisionSoft MiceSlice program.

2.3.4

Histology

Staining was accomplished using the Purdue Neuroprostheses Research Lab standard
histology protocol: primary and secondary antibodies are incubated consecutively at 4
degrees Celsius for 48 hours each, with multiple washes before and after in order to
remove excess antibodies. The wash solution used in the procedure is composed of 1%/1%
Volume/Volume Normal Goat Serum and .3% Triton X-100 in HEPES buffered Hank’s
Saline with Sodium Azide (HBHS). The specifics of the procedure are detailed in Table 1.
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Table 1: Staining Protocol
Washing/Blocking

Samples washed with HBHS 3 times for 5 minutes
each, then blocked for two hours in wash solution.
Flip after one hour.
Incubate in primary antibodies for 48 hours at 4
celsius. Flip samples after 24 hours.
Wash 6 times for 3 minutes each using wash
solution. Then wash 6 times for 1 hour, flipping
samples after 3 washes.
Incubate in secondary antibodies for 48 hours at 4
celsius. Flip samples after 24 hours.
Wash 6 times for 3 minutes each using wash
solution. Then wash 6 times for 1 hour, flipping
samples after 3 washes.

Primary
Washing
Secondary
Washing

In the experiment we utilized antibodies specific to Neuronal Nuclei (NeuN), Blood
Vessels / Endothelial Cells (CD31), and Hoechst 33258 in order to stain cell nuclei and
allow for the segregation of different cells. Secondary antibodies were Alexa Fluor 568
and Alexa Fluor 633, with Hoechst added during the secondary antibody application.
These were diluted into the previously described wash solution: dilutions of antibody to
solution were as follows:
Table 2: Sample Staining
Neuronal Nuclei

Microglia

Blood Vessels

Nuclei

Primary

NeuN – 1:400

Endogenous

CD31 – 1:200

-

Secondary

AF 633 – 1:500

Endogenous

AF 568 – 1:300

Hoechst 33258
0.5 ug/ml

After completion of staining, samples were organized into a 24-well plate and cleared
using the SeeDB clearing agent (Ke, Fujimoto, & Imai, 2013), chosen for its rapid
clearing effect of brain tissue along with the minimal change in the sample size over the
course of clearing. The SeeDB solution is composed of Į-thiolglycerol ȝOPO and
various concentrations of fructose dissolved into water, and the clearing technique itself
is performed by changing the SeeDB solution over the course of up to 3 days, as detailed
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below. Samples submerged in SeeDB must be left at room temperature to prevent
precipitation of fructose.
Table 3: SeeDB Clearing
Concentration (Wt/Volume)

Time (Hours)

20% Fructose

4-8

40% Fructose

4-8

60% Fructose

4-8

80% Fructose

12

100% Fructose

12

115% Fructose
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Samples were then mounted between two glass coverslips in order to allow for imaging
of both sides of the sample. In order to construct this mount, PDMS spacers were cut to
appropriate sizes matching the thickness of the samples using a vibratome and then used
in conjunction with BluTack to prevent sample damage caused by over compression
during flattening of the sample and mount. Following compression, the whole mount was
sealed using a bead of Kwik-Sil in order to prevent media from dissolving or leaking
during extended imaging sessions, an issue we had previously encountered when imaging
with the SeeDB solution as a mounting media. A diagram of the mount, along with a
picture of the actual mount in use, is shown in Figure 4.

21

Figure 4: Sample Mounting
(A) A schematic of the prep utilized to image from both sides of the sample. (B) Mount in use.

2.3.5

Imaging

Brain slices were imaged using a Zeiss LSM 710 inverted confocal microscope, using the
Smart Setup controls to automatically generate the correct settings (Hoechst 33528,
EGFP, Atto-555, AlexaFluor-633). Laser lines were broken into two separate tracks to
minimize cross-talk: 405nm & 633nm, 488nm & 561nm. Each of these combinations has
sufficiently separated excitation and emission spectra that they can be imaged at once, in
order to save time. Images were taken using a 25x Oil objective at .7 zoom, a pinhole of 1
AU, and a Z step size of 1.13 microns to create 486 x 486 x 250 micron dimension image
stacks of tissue. Images are taken at 2048 x 2048 pixels, giving us 4.216 pixels per
micron. These dimensions allow for the collection of imaging data wholly containing a
portion of the implant as well as nearby tissue. DCHIST slices were imaged four times,
twice on either side on both the control (undamaged) hemisphere and the hemisphere
containing the electrode.
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2.3.6

Post-Processing and Quantification

Z-stack image files were then imported into FIJI (Schindelin et al., 2012), an open source
image processing suite, for post-processing. Channel separation and vessel identification
were performed using a macro utilizing features already included in the program, with a
separate macro/function written for vessel quantification. A flowchart detailing the basics
of this method is shown in Figure 5, and the current version of the code is contained in
the Appendix. In order to save time and efficiently process the data, each Z level is
processed separately by the cleaning software. The macro first loads one plane of the
image, then runs Gaussian Blur at a sigma value of 1. After the blur, the Tubeness
function is used to segment cylindrical structures from the image. At completion of the
single Z plane, the file is saved and then a new plane is loaded – this continues until the
entire image sequence has been processed. The series is then repeated again at a sigma
value increased by 1 (1 , 2, 3, 4, and 5 values for sigma were used in this project) . After
completion of all sigma values, images are then added together in order to create one
composite image. The variation of the sigma values allows for the macro to extract
vessels with various diameters, allowing us to characterize all the vasculature rather than
a subsection of it.
Following the completion of the averaged image, the user decides on a threshold setting
and runs Connected Regions to remove structures smaller than a certain size. The file
output by this process must be converted to binary in order to facilitate the next
quantification step. The second macro contained utilizes the Skeletonize plugin to erode
vessels down to their centerlines; this data is then loaded into a modified Analyze
Skeleton plugin in order to extract data about the vessel. By selecting each vessel with a
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wand tool and then summing the voxels contained within it on all the Z planes the
structure is present in, we are able to quantify and output relevant data such as length,
diameter, and beginning and end points. Vessel data was then collected into histograms
based on normalized vessel diameter and time points. The normalization process is
achieved by segmenting each vessel into 1 micron long sections and then counting the
number of sections contained – this allows us to control for the fact that the larger vessels
will contain more pixels than the smaller vessels. This mismatch in pixel amount means
that calculations based just on the amount of voxels contained within each object will be
skewed towards larger vessels. The data generated was used in conjunction with the
Kolmogorov-Smirnov test (K-S test), in order to determine if there were statistical
differences between the histograms generated in this fashion.
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Figure 5: Post-Processing Flowchart
Flowchart detailing how the coding components function

2.4

Results

Post-processing of our images generated length and diameter values for vascular
segments contained within each image. The total number of segments within each image
is listed in Table 3. Within this data there is a slight trend towards a greater number of

25
segments calculated within the control hemisphere images. Histograms of data from time
points 0, 3, and 7 day implantation are shown in figures 9, 10, and 11.
Table 4: Vascular Segments Per Image
Image Name | Time Point

Vascular Segments Control | Implant

Vaso 17 | 0 Day

268909 | 97897

Vaso 11 | 0 Day

147594 | 286996

Vaso 16 | 0 Day

690761 | 538496

Vaso 10 | 3 Day

497601 | 394994

Vaso 14 | 3 Day

585998 | 345610

Vaso 15 | 3 Day

525687 | 424891

Vaso 4 | 7 Day

471075 | 274157

Vaso 5 | 7 Day

514705 | 334036

Vaso 8 | 7 Day

715861 | 730091

Unprocessed maximum projection images of microglial, vascular, and neuronal signal are
shown in figures 7, 8, 9. Examination of the microglial images show activation by day 3,
as cell bodies enlarge and processes shorten, and apparent migration by day 7, where the
distribution of microglia is tightly packed around the implant site. Vasculature in the
implanted region appears to be enlarged at 3 and 7 days in comparison with control
images. Neuronal nuclei appear normal at 0 days implanted, but their morphology in
regions surrounding the implant appears to elongate and shrink by 3 days implanted. This
shift in morphology is less apparent by 7 days implanted.
After running the Kolmogorv-Smirnov Test with Į = 0.05, results show that control data
and implant data have statistical differences between them and cannot be drawn from the
same continuous distribution. The results also indicate that the different control
hemispheres between animals and time-points cannot be drawn from the same
distribution, as the K-S test rejects the null hypothesis when comparing the various
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datasets. In order to explore this, median data from each distribution was used to
determine trends in both control and implant hemispheres as the time implanted increases
(Figure 12). This comparison shows an increase in the control vascular diameter median
over time, going from 3.82 ȝP initially to 4.31 by 7 days implanted. It also shows an
increase and subsequent decrease in the vascular diameter of the region surrounding the
implant: the vessel median begins at 3.26 ȝP, goes up to 5.58 ȝm by 3 days of
implantation, and drops down to 5.12 ȝP by 7 days. This matches with the overall trends
shown in figures 9-11, with similar vascular distributions at 0 days implanted, wider
distributions of vasculature
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Figure 6: Microglial Comparison
Images A, C, and E are representative images of the control hemispheres at 0, 3, and 7 day time points. Images B, D,
and F show implanted hemispheres at the same time points. The dotted line represents the location of the implant. All
images are of microglia, at 488 nm wavelength. Scale bar is 60 ȝm in length.
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Figure 7: Vascular Comparison
Images A, C, and E are representative images of the control hemispheres at 0, 3, and 7 day time points. Images B, D,
and F show implanted hemispheres at the same time points. The dotted line represents the location of the implant. All
images are of vasculature, at 561 nm wavelength. Scale bar is 60 ȝm in length.
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Figure 8: Neuronal Comparison
Images A, C, and E are representative images of the control hemispheres at 0, 3, and 7 day time points. Images B, D,
and F show implanted hemispheres at the same time points. The dotted line represents the location of the implant. All
images are of neuronal nuclei, at 633 nm wavelength. Scale bar is 60 ȝm in length.
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Figure 9: Day 0 comparison of Control and Implant data.
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Figure 10: Day 3 comparison of Control and Implant data.
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Figure 11: Day 7 comparison of Control and Implant data.

33

Figure 12: Comparison of median vascular diameter.
Median vascular diameter in control and implant hemispheres at 0, 3, and 7 day time points. Bars show standard
deviation of median within samples used at each time point.

Figure 13: Processed vs Unprocessed
Comparison between processed data (A) and actual data (B). Scale bar is 60 ȝm in length
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Figure 14: Fragmentation of larger vessels after post-processing

2.5

Discussion

Contradictory to our initial hypothesis, our results do not show vasoconstriction in the
region surrounding the implant at up to 7 days post implantation. We were able to
successfully quantify and follow trends in the dilation of blood vessels in the area
surrounding the implant, but our results show vasodilation in response to the injury
instead of vasoconstriction. Our results imply that the vasodilation caused by the initial
injury and the inflammatory response are compensated for by day 7, when we begin to
see a higher population of microglia surrounding the implant – this compensation is
likely due to the local microglial activation and secretion of anti-inflammatory cytokines
(Aloisi, 2001). In addition to the vasodilation occurring in the implanted region, our data
suggests vasodilation in the control hemisphere over time as well. While the changes in
vascular diameter are not as pronounced as those present in the implant hemisphere, this
data supports previous results published showing disruption of the blood brain barrier in
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the hemisphere contralateral to the initial damage; this could easily be due to vascular
dilation disrupting the tight end junctions forming the blood brain barrier. The occurrence
of vasoconstriction may occur after the normal vasodilation has taken its course – the
abundance of anti-inflammatory secretions in combination with the disrupted ability of
the brain to auto-regulate could lead to overcompensation in response to the injury.
As seen in the graphs, some of our data is skewed towards smaller vessels – while this
may be due to actual vasoconstriction, it is more likely due to our processing method
breaking down some larger vessels into smaller components, shown above in Figure 14.
With this in mind, future processing of this data will attempt to characterize these vessels
further, in order to give a more accurate description of the changes to vasculature and
comparison between the control and implant hemispheres.

2.6

Future Research Directions

As we were unable to isolate any instances of vasoconstriction within the time constraints
of this study, the next research goal would be to characterize the vasculature at later time
points. One of the reasons for this is that an accepted time point for when the acute
portion of the foreign body response resolves is at a month in – if vasoconstriction occurs
at or after this time point, it could influence the local neuronal population further and
degrade the function of a neuronal implant. This vasoconstriction could be due to a
continued disruption of the auto-regulatory properties of the local vasculature due to the
continued presence of an implant, an overabundance of anti-inflammatory signaling from
activated glial cells nearby, or even vasoconstriction due to a lessened metabolic need
caused by local cell death. Other goals may involve characterizing the vasculature using
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the same method in response to anti-inflammatory drugs or treatment, in an attempt to
discover how this influences the dilation or constriction of local vasculature over time,
and what consequences may occur due to modifying the brain’s auto-regulatory
capabilities. Of particular interest for this research would be utilizing a window applied
over a craniotomy for in-vivo characterization of the vascular response to injury; this
allows for real time quantification of live vasculature, which would allow for a more
accurate characterization and understanding of vasodilation or constriction and when it
occurs. Characterization of the links between astrocytes, vascular changes, and the blood
brain barrier would also be useful to quantify, as completely understanding this
relationship is an important step towards maintaining implant function while also keeping
the brain healthy.

2.7

Conclusions

In the case of vasculature and its part in the inflammatory and foreign body responses,
vasoconstriction and vasodilation are two faces of the same coin. Both of these conditions
can cause severe damage to local tissue and the brain if left unchecked, but are also
necessary for normal function and as a result are tightly regulated in a healthy brain. The
loss of the auto-regulatory control following injury is concerning, and has the potential to
cause damage to nearby tissue in normally innocuous situations that would be
compensated for normally. In this study, we were able to characterize vasodilation at up
to 7 days post implantation, along with data indicating the occurrence of vasodilation in
the opposite hemisphere where no damage had occurred. The vasodilation in the opposite
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hemisphere could be an attempt to compensate for the damaged hemisphere, or even
trying to compensate for the disrupted vascular regulation on the damage side.
Quantification of vasculature and other forms of tube-like networks, including neurons, is
a difficult thing to accomplish, and is at best only partially automated. Unlike previous
methods which utilize human input to determine the beginning and end of a segment of
vasculature or neuron, our methodology is able to isolate and quantify tube-like structures
on its own, only necessitating human input currently to get the most accurate skeleton
through thresholding. By utilizing this technique, it may become easier to setup dataprocessing pipelines and facilitate the rapid quantification of connected networks without
human intervention.
In conclusion, our techniques in both imaging and post-processing allow us to quantify
the diameter and length of vasculature present in the cortex while only using standard
histological methods. The results we collected follow along the trends seen previously
with the vascular response to implantation. These results show that we can quantify the
effects on vasculature without having to resort to complicated surgical preps or expensive
microscopy solutions, and allows for future research to quantify the vascular response in
a fast and cost-efficient method.
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APPENDIX

Cleaning Code
Runnable as a .ijm (FIJI Macro) file
// This short macro looks for all the files called .tif
// in a directory and preprocesses them for "tubeness"
// using sigma = 3. It currently allows you to select up to
// 4 images at the same time for concurrent processing.
di = newArray('0','0','0','0');
for (k=0; k<4; k++){
di[k] = getDirectory("Choose a Directory ");
}
for (k=0; k<4; k++){
file_names = newArray("1", "2", "3", "4", "5");
file_smaller = newArray("0");//, "1", "2", "3", "4", "5", "6", "7", "8", "9");
d = di[k];
list = getFileList(d);
File.makeDirectory(d + "/averaged/");
for (f=0; f<5; f++){
File.makeDirectory(d + "/" + file_names[f]+ "/");
for (f1=0; f1<1; f1++){
File.makeDirectory(d + "/" + file_names[f]+ "/" + file_smaller[f1] + "/");
for (i=0; i<list.length; i++) {
fullName = d + list[i];
saveName = d + "/" + file_names[f]+ "/" + file_smaller[f1] + "/" + list[i];
sigmaName = "sigma=" + file_names[f] + "." + file_smaller[f1] + " use";
if (endsWith(fullName, ".tif")) {
open(fullName);
t = getTitle();
run("Tubeness", sigmaName);
selectWindow("tubeness of "+t);
dotIndex = lengthOf(saveName) - 4;
n = substring(saveName,0,dotIndex) + ".tubes.tif";
saveAs("Tiff", n);
close();
close();
}
}
}
}
//Average the files
f_name = "/1/0/";
list2 = getFileList(d+f_name);
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f_name = "/2/0/";
list2 = getFileList(d+f_name);
for (i=0; i<221; i++) {
fullName = d + f_name+ list2[i];
fullName2 = d + "/2/0/"+ list2[i];
saveName = d + "/averaged/" + list2[i];
if (endsWith(fullName, ".tif")) {
open(fullName);
t = getTitle();
open(fullName2);
t2 = getTitle();
imageCalculator("Add create", t,t2);
selectWindow("Result of "+t);
dotIndex = lengthOf(saveName) - 4;
n = substring(saveName,0,dotIndex) + ".tif";
saveAs("Tiff", n);
close();
close();
close();
}
}
}

PROCESSING CODE

Runnable as a jython script
from ij import IJ
from ij import ImagePlus
from skeleton_analysis import AnalyzeSkeleton_
from Skeletonize3D_ import Skeletonize3D_
from skeleton_analysis import Point
from ij.gui import Wand
from ij.plugin.filter import Analyzer
from ij.process import PolygonFiller
from ij.measure import ResultsTable
import math
from os import listdir
from os.path import isfile, join
###########
# This program is a python modification of the volume calculator program found at
# https://github.com/fiji/fiji/commit/c220c0bfb61f1f786d9af5a510b588162cb751a0 .
# This program performs volume calculation for an entire binary image without user
# input.
########################
# Processing Constants
########################
minEdgeLength = 2.0;
AnalysisDirectory = "C:/ "
# Replace Analysis Directory with directory containing images in question
######################################
# Process each .tif file in directory
######################################
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files = listdir(AnalysisDirectory) #listdir will give the file names
for f in files:
if f.endswith(".tif"):
fullName = join(AnalysisDirectory, f)
print 'Opening: ' + fullName
#####################
# Get original image
#####################
print('Loading Image...')
#original = IJ.getImage() # Opens image selected currently open and selected
original = IJ.openImage(fullName)
imp = original.duplicate()
print('Image Loaded')
##############
# Skeletonize
##############
# http://fiji.sc/javadoc/Skeletonize3D_/Skeletonize3D_.html
print('Begining Skeletonization.........')
skeletonize = Skeletonize3D_()
skeletonize.setup("",imp)
skeletonize.run(imp.getProcessor())
print('Skeletonization Complete')
###################
# Analyze Skeleton
###################
# http://fiji.sc/javadoc/skeleton_analysis/AnalyzeSkeleton_.html
#
https://github.com/fiji/AnalyzeSkeleton/blob/46eac2bbe8f4e2492324bc7457780980dd17cc3f/src/main/java/skeleton_a
nalysis/AnalyzeSkeleton_.java
print('Begining Skeleton Analysis.........')
analyze = AnalyzeSkeleton_()
analyze.setup("", imp)
pruneIndex = AnalyzeSkeleton_.SHORTEST_BRANCH
pruneEnds = False
shortPath = False
silent = True
verbose = True
asResults = analyze.run(pruneIndex, pruneEnds, shortPath, imp, silent, verbose)
# Count number of total edges
edgeCount = 0;
for i in range(asResults.getNumOfTrees()):
countEdges = asResults.graph[i].getEdges()
for edge in countEdges:
if (edge.getLength() > minEdgeLength):
edgeCount += 1
print('Skeleton Analysis Complete')

############################
# Analyze Skeletonized data
############################
# https://github.com/fiji/fiji/commit/c220c0bfb61f1f786d9af5a510b588162cb751a0
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print('Begining Volume Calculation..........')
currentEdge=0
# New results table
extra_rt = ResultsTable()
extra_head = ['Branch length','V1 x', 'V1 y', 'V1 z','V2 x','V2 y', 'V2 z', 'Voxels (um^3)', 'Diameter (um)']
# Conversion factor for voxels to um cubed
volumeMultiplier = imp.getCalibration().pixelDepth *imp.getCalibration().pixelHeight *
imp.getCalibration().pixelWidth
# Calculate slice processors for each segment of the image
sliceProcessor = [None]*original.getNSlices()
for i in range(original.getNSlices()):
sliceProcessor[i] = original.getStack().getProcessor(i+1)
# Iterate through all treesand edges (aka sections of vasculature)
for i in range(asResults.getNumOfTrees()):
listEdges = asResults.graph[i].getEdges()
for edge in listEdges:
# Only analyze edges with a length further than xxx um (currently not removing edges)
if (edge.getLength() > minEdgeLength):
totalVoxels = 0
currentEdge = currentEdge + 1
# Start of edge
v1 = edge.getV1()
p1 = v1.getPoints().get(0)
# end of edge
v2 = edge.getV2()
p2 = v2.getPoints().get(0)
# For all the points along this edge:
# Move to the slice number z + 1 and run the Wand at the x, y
# coordinates of the original (thresholded image).
# NB: Adding 1 to slice number because this z is 0-based.
####sliceProcessor = original.getStack().getProcessor(p1.z + 1)
# http://rsbweb.nih.gov/ij/developer/api/ij/gui/Wand.html
wand = Wand(sliceProcessor[p1.z])
wand.autoOutline(p1.x, p1.y)
# Calculate area within outline of vasculature
poly = PolygonFiller(wand.xpoints,wand.ypoints,wand.npoints)
mask = poly.getMask(original.width+1,original.width+1)
count = 0
xMin = min(wand.xpoints.tolist())
xMax = max(wand.xpoints.tolist())
maskArray = mask.getIntArray()
for y in range(xMin,xMax):
totalVoxels += (sum(maskArray[y])/255)
# Need to watch for a change in the value of the z coordinate
lastZpoint = (p1.z + 1)
for point in edge.getSlabs():
# If the z position has not changed skip this point because
# the previous pixel is connected to this pixel.
if (point.z + 1) != lastZpoint:
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####sliceProcessor = original.getStack().getProcessor(point.z + 1)
wand = Wand(sliceProcessor[point.z])
wand.autoOutline(point.x, point.y)
# Calculate area within outline of vasculature
poly = PolygonFiller(wand.xpoints,wand.ypoints,wand.npoints)
mask = poly.getMask(original.width+1,original.width+1)
count = 0
maskArray = mask.getIntArray()
xMin = min(wand.xpoints.tolist())
xMax = max(wand.xpoints.tolist())
for y in range(xMin,xMax):
totalVoxels += (sum(maskArray[y])/255)
#for x in range(mask.width):
# totalVoxels += (sum(maskArray[x])/255)
lastZpoint = (point.z + 1)
if lastZpoint != (p2.z + 1):
# get the last point and count the surrounding pixels
####sliceProcessor = original.getStack().getProcessor(p2.z + 1)
wand = Wand(sliceProcessor[point.z])
wand.autoOutline(p2.x, p2.y)
# Calculate area within outline of vasculature
poly = PolygonFiller(wand.xpoints,wand.ypoints,wand.npoints)
mask = poly.getMask(original.width+1,original.width+1)
count = 0
maskArray = mask.getIntArray()
xMin = min(wand.xpoints.tolist())
xMax = max(wand.xpoints.tolist())
for y in range(xMin,xMax):
totalVoxels += (sum(maskArray[y])/255)
# Calculate the diameter of the vasculature
diameter = 2*math.sqrt((totalVoxels*volumeMultiplier)/(edge.getLength()*math.pi))
# Add to output table
extra_rt.incrementCounter();
extra_rt.addValue(extra_head[0], edge.getLength())
extra_rt.addValue(extra_head[1], edge.getV1().getPoints().get(0).x * imp.getCalibration().pixelWidth)
extra_rt.addValue(extra_head[2], edge.getV1().getPoints().get(0).y * imp.getCalibration().pixelHeight)
extra_rt.addValue(extra_head[3], edge.getV1().getPoints().get(0).z * imp.getCalibration().pixelDepth)
extra_rt.addValue(extra_head[4], edge.getV2().getPoints().get(0).x * imp.getCalibration().pixelWidth)
extra_rt.addValue(extra_head[5], edge.getV2().getPoints().get(0).y * imp.getCalibration().pixelHeight)
extra_rt.addValue(extra_head[6], edge.getV2().getPoints().get(0).z * imp.getCalibration().pixelDepth)
extra_rt.addValue(extra_head[7], totalVoxels*volumeMultiplier)
extra_rt.addValue(extra_head[8], diameter)
# Print out current table data and progress
print 'Edge %d of %d, Length = %f, Diameter = %f' % (currentEdge,edgeCount,edge.getLength(),diameter)
print('Volume Calculation Complete')
#extra_rt.show("Branch information")
######################################
# Save output file
######################################
outName = 'Analysis' + f[:-3] + 'xls'
fullOutName = join(AnalysisDirectory, outName)
print 'Results saved in: ' + fullOutName
extra_rt.saveAs(fullOutName)

